|
|
Volumn 17, Issue 3, 1996, Pages 90-94
|
|
α2-Adrenoceptors take centre stage at Nashville meeting
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE;
2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE;
2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE;
2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN;
6 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 9 (3 METHYL 2 BUTENYLOXY) 1H 3 BENZAZEPINE;
7 CHLORO 3,4,5,6 TETRAHYDRO 4 METHYL 2 VINYLTHIENO[4,3,2 EF][3]BENZAZEPINE;
ALPHA 2 ADRENERGIC RECEPTOR;
ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BENOXATHIAN;
BRIMONIDINE;
CATECHOLAMINE;
CORYNANTHINE;
EFAROXAN;
GUANINE NUCLEOTIDE;
GUANINE NUCLEOTIDE BINDING PROTEIN;
GUANOSINE 5' O (3 THIOTRIPHOSPHATE);
IDAZOXAN;
MIANSERIN;
OXYMETAZOLINE;
PHENTOLAMINE;
PRAZOSIN;
RAUWOLSCINE;
RECEPTOR SUBTYPE;
SPIROXATRINE;
TOLAZOLINE;
CONFERENCE PAPER;
DRUG DESIGN;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN STRUCTURE;
RECEPTOR BINDING;
REGULATORY MECHANISM;
SIGNAL TRANSDUCTION;
|
|
EID: 0029988789
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/0165-6147(96)30004-7 Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (1)
|
